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1. Introduction 
Liver transplantation is the only potentially curative treatment for patients with end-stage 
liver disease or unresectable primary hepatic tumors. Biliary atresia accounts for 
approximately 40% of liver transplant performed in children in the United State (Carter et 
al, 2006). Intra-hepatic cholestasis and inborn metabolic errors resulting in cirrhosis 
constitute the second most common group. Progressive liver failure and finally acute liver 
failure following hepatitis or drug toxicity represent a small referral group. 
First human liver transplantation was performed by Starzl in 1963 at the University of 
Colorado Health Science Center on a three years old patient with biliary atresia and the 
patient died before the completion of the surgery (Starzl et al, 1963). First successful liver 
transplantation was performed in 1967 on an eighteen months old patient with malignant 
liver tumor and the patient survived for 400 days before she succumbed from disseminated 
malignancy (Carter et al, 2006). Survival after pediatric liver transplantation has improved 
significantly in recent decades because of the advances in surgical techniques, 
immunosuppressive therapy, and peri-operative care (Jain et al, 2002). Pediatric liver 
transplant recipients also have benefited from major technologic advances in diagnostic and 
interventional radiology. Radiology has acquired a key role in both pediatric and adult liver 
transplantation programs because it allows early detection and prompt treatment of post-
transplantation vascular and nonvascular complications, helping to improve graft and patient 
survival and obviating surgical revision or repeat transplantation in most cases (Amesur & 
Zajko, 2006; Rose et al, 2001; Sze & Esquivel, 2002). Various interventional radiology 
procedures may be applied during the follow-up of pediatric liver transplant recipients to 
detect and diagnose graft disease and to treat vascular and biliary complications. The 
interventional radiology procedures most commonly used in this context include 
percuntaneous and transjugular liver biopsies for the diagnosis of graft disease; angioplasty 
and stent placement for the treatment of vascular stenosis or occlusion; biliary drain 
placement for the treatment of biliary strictures; coil embolization and stent graft placement 
for the treatment of pseduoaneurysm and artriovenous fistulas. Brief description of the 
surgical technique for split liver transplantation, the technical considerations involved in 
interventional radiology procedures, the expected results, and the possible complications 
are described in details in this chapter. 
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2. Surgical technique for split liver transplantation 
Reduced liver technique or split liver transplantation represents a major advance in liver 
transplantation that significantly reduced the waiting period for liver transplantation. 
Most pediatric liver transplantations are performed today by using left lateral segmental 
(II&III) transplantation or so called split liver transplantation (Fig. 1), a technique that 
accommodates the needs of pediatric patients without depleting the pool of organs available 
for adult patients with excellent patient and graft survival rate (90 and 87% respectively) 
(Deshpande et al, 2002) . Radiologist should be familiar with the surgical techniques used in 
the transplantation such as Piggy back technique for the anastomosis between the inferior 
vena cava of the recipient and the hepatic veins of the graft, end to end or interposition 
conduit for the hepatic arterial and the portal venous anastomosis, and Roux-en-y technique 
for the hepaticojejunostomy biliary anastomosis (Fig. 2). 
 
Fig. 1. Schematic diagram of split liver to provide two grafts from single donor, left lateral 
segment for a child and the right lobe for an adult recipient 
  
Fig. 2. Schematic diagram illustrating orthotopic segmental liver transplantation. Piggy back 
hepatic vein to IVC anastomosis. Hepatic arteries and portal veins end to end anastomosis. 
Roux-en-y hepaticojejunostomy biliary anastmosis 
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3. Imaging spectrum and image-guided procedures for the management of 
complications after split liver transplantation 
3.1 Organ rejection 
Organ rejection develops in about 50% of patients, but improved immunosuppressive 
medications permit successful management of this problem in most cases (Zalasin et al, 
1998). The ultrasound appearances of acute rejection are nonspecific, and the only 
identifiable abnormality is heterogeneity of the liver parenchyma, which may, however, 
have other causes (Crossin et al, 2003; Marder et al, 1989; Zalasin et al, 1998). The role of 
imaging consists of excluding these other possible causes, which can manifest with clinical 
signs and symptoms similar to those of acute rejection (Crossin et al, 2003). The diagnosis of 
acute rejection, one of the most serious complications following liver transplantation, is 
established by graft biopsy and histologic study (Nghiem, 1998). 
3.1.1 Percutaneous liver biopsy 
Percutaneous ultrasonography (US)-guided random liver biopsy is frequently requested 
after pediatric liver transplantation. Any alteration in liver function test results that cannot 
be explained on the basis of findings at diagnostic imaging requires a liver biopsy to exclude 
organ rejection. US guidance of biopsy is necessitated by the small volume of the 
transplanted liver, especially in split-liver transplantation, and the need to avoid perforating 
the bowel, other adjacent organs, and important intrahepatic vascular structures. If a 
coagulation defect is present (eg, platelet count of less than 50 × 1000 per microliter, 
prothrombin activity less than 50% of the normal level), patients receive an infusion of 
platelets, fresh frozen plasma, or both. If the presence of massive perihepatic ascites make 
liver biopsy infeasible, a percutaneous drainage catheter might be placed first to eliminate 
the ascites. The use of a coaxial technique in pediatric patients also has been described. In 
this procedure, a coaxial sheath is used to inject slurry of microfibrillar collagen into the 
needle tract to reduce the risk of bleeding after biopsy (Hoffer, 2000). An antibiotic is 
administered prophylactically before the procedure. Core biopsies are performed by using 
an 18-gauge needle and monitored anesthesia care with additional local anesthesia 
administered at the site selected for puncture. An anterior approach is usually the only one 
possible in patients with a split-liver transplant. After the biopsy, manual compression is 
applied to the puncture site for ten minutes. Possible major complications of percutaneous 
liver biopsy are bleeding, hemobilia, arterioportal fistula, and infection; these have been 
reported in 4.6% of pediatric patients who have undergone the procedure (Amaral et al, 
2006).  
3.1.2 Transjugular liver biopsy 
The transjugular approach is widely used for random liver biopsies in adult patients with 
massive perihepatic ascites, severe coagulopathy, or both because it is associated with a 
lower rate of bleeding complications than is percutaneous biopsy (Furuya, 1992). The 
transjugular technique incurs a lower risk of hemorrhage because a biopsy specimen is 
acquired through the hepatic vein and any bleeding from the puncture site remains within 
the vascular space. In addition, if there are clinical signs of portal hypertension, the hepatic 
vein pressure gradient can be measured during the transjugular biopsy procedure. The use 
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of combined US and Fluoroscopic guidance during transjugular hepatic biopsies in pediatric 
patients has been reported to help reduce the risk of capsule perforation (Habdank, 2003). 
Complications of this biopsy procedure, which have been reported in 3%–11% of cases, 
include subcapsular hematoma, intraperitoneal bleeding, Subclavian artery puncture, 
pneumothorax, and hemothorax (Furuya, 1992; Kaye et al, 2000; Habdank, 2003). Transjugular 
random liver biopsy with catheterization of the right hepatic vein also has been reported in 
pediatric whole-liver transplant recipients (Habdank, 2003). Prophylactic antibiotics are 
routinely administered before the biopsy procedure, and an infusion of platelets or fresh 
frozen plasma is administered if coagulation defects are present. The small size of the liver 
in pediatric patients with a left lateral transplant and patient weight of less than 15 kg are 
considered relative contraindications to the procedure. 
3.2 Vascular complications and treatment 
Vascular complications that occur after pediatric liver transplantation are associated with 
high rates of morbidity, graft loss, and mortality (Sieders et al, 2000). These complications 
may involve the hepatic artery, hepatic vein, portal vein, or inferior vena cava. Most 
vascular complications appear within 3 months after transplantation. Clinical manifestations 
vary from mildly elevated values on hepatic function tests to fulminant hepatic failure 
(Bergey et al, 1998; Furuya, 1992; Hasegawa et al, 2002; Hoffer, 2000). Because their clinical 
manifestations often are indistinguishable from those of biliary complications, graft rejection, 
graft dysfunction, and infection, imaging is necessary for diagnosis. Color Doppler US, 
Multidetector computed tomography (CT), and magnetic resonance (MR) imaging all are 
useful for the diagnosis and follow-up. US is the primary screening modality used for the 
detection of vascular complications and imaging by Doppler US starts intra-operatively, in 
the ICU and twice daily for the first three days. The normal Doppler US parameters should 
include hepatopetal (toward the liver), pulsatile, low resistant flow in the hepatic artery 
with systolic velocity of more than 30 cm/s (fig. 3a), hepatopetal flow in the portal vein  
with velocity of at least 10 cm/s (fig. 3b) and phasic hepatofugal (outward the liver)  
 
Fig. 3. Normal Doppler US study of the hepatic artery and portal vein after liver 
transplantation. (A) Pulsatile, low resistant hepatopetal flow in hepatic artery with velocity 
of 58.6 cm/s. (B) Phasic hepatopetal flow in portal vein with velocity of 18.5 cm/s 
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flow in the hepatic veins. MR angiography is performed to confirm abnormalities 
demonstrated at US or in patients in whom the US study is suboptimal. CT.scan is less 
frequently used today in this patient population due to the concern about the high radiation 
dose associated with it. Conventional vascular studies are currently reserved for 
endovascular treatment of these complications. 
3.2.1 Hepatic artery stenosis 
Hepatic artery stenosis occurs in 11%–20% of patients who have undergone pediatric liver 
transplantation (Moray, 2005). Most hepatic artery stenosis arise at the anastomosis site 
within 3 months after transplantation and are due to the small caliber of the arteries or to 
arterial injury by a vascular clamp during transplantation. However, nonanastomotic 
stenosis may occur in cases of graft rejection or necrosis. Early diagnosis and intervention 
may help to reduce ischemic damage to the graft, consequent bile duct damage, and 
progression to hepatic artery thrombosis. Doppler US is the imaging modality of choice for 
diagnosis and follow-up. The reported sensitivity of Doppler US for the detection of hepatic 
artery stenosis is 80%–90% (Abbasoglu et al, 1997; Crossin et al, 2003; Kok et al, 1998). 
Spectral broadening and focal accelerated velocity greater than 2 m/sec (Crossin et al, 2003; 
Nghiem et al, 1996; Platt et al, 1997) at the site of arterial anastomosis indicate stenosis. 
However, the site of narrowing is often difficult to identify by US due to overlying bowel 
gas especially in conduit graft, and the diagnosis is usually made on the basis of the Doppler 
US findings obtained distal to the stenosis. Intrahepatic arterial waveforms distal to the 
stenosis display a tardus parvus pattern with a decreased resistive index (<0.5) and 
prolonged acceleration time (80 msec) (Fig. 4a) (Dodd et al, 1994; Platt et al, 1997; Vignali et 
al, 2004). Associated turbulences distal to the stenosis are commonly observed at color 
Doppler US (Crossin et al, 2003; Platt et al, 1997). A tardus parvus pattern may be a normal 
finding during the first 72 hours after transplantation due to edema at the anastomotic site 
(Kok et al, 1998). In these cases, serial US will reveal a normal waveform 3–4 days after 
transplantation. MR angiography offers an alternative noninvasive technique for confirming 
the stenosis and for better evaluation of the anastomosis and the entire hepatic artery (Ito et 
al, 2000; Vignali et al, 2004). Conventional arteriography is currently reserved for 
endovascular treatment of the stenosis (Boraschi& Donati, 2004; Vignali et al, 2004). Early 
hepatic artery stenosis (less than two weeks post transplantation) should be treated 
surgically because endovascular treatment has the risk of suture line rupture. The use of 
percutaneous transluminal angioplasty with or without stent placement to treat hepatic 
artery stenosis in adult and pediatric liver transplant recipients have been reported 
(Hashikura et al, 2001; Kok et al, 1998; Nghiem et al, 1996). Possible complications that have 
been described include dissection, pseudoaneurysm, and rupture of the hepatic artery. 
When Doppler US or MRA findings are suggestive of hepatic artery stenosis, hepatic 
arteriography is performed by using a transfemoral approach and a standard 4-F 
angiographic catheter with monitored anesthesia care or general anesthesia. A coaxial 
microcatheter is then advanced through the stenosis, and the trans-stenotic pressure 
gradient is measured. If a significant pressure gradient is present (>10 mm Hg), angioplasty 
is performed. Before angioplasty, 0.2 mg nitroglycerin and 100 IU heparin per kilogram of 
body weight are infused into the hepatic artery to reduce the risks of spasm and thrombosis. 
A 6-F guiding catheter is inserted, and a balloon catheter is advanced over a 0.018- or 0.014-
inch stiff wire. The balloon diameter varies in accordance with the diameter of the hepatic 
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artery (Figs. 5&6). Procedural success is defined as the reduction or absence of stenosis at 
arteriography, accompanied by a significant reduction of the trans-stenotic pressure 
gradient. Angioplasty is technically successful in about 80% of the cases with restenosis rate 
of 30-60%. The long-term patency of stents is unknown; for this reason, stent placement in 
pediatric patients is recommended only if angioplasty fails or if complications such as 
hepatic artery dissection or rupture ensue. Doppler US is performed the day after the 
procedure to obtain baseline measurements of the intra and extrahepatic arterial resistive 
index (RI) and systolic acceleration time for comparison with follow up measurements (Fig. 
4c). 
  
Fig. 4. Early hepatic arterial stenosis (Surgically treated). (A) Doppler US performed day 5 
post liver transplant shows tardus parvus waveform and low acceleration times in the right, 
left and main hepatic arteries. (B) Catheter angiogram, subtracted and un-subtracted images, 
confirms the stenosis at the proper hepatic artery. (C) post surgical revision follow up 
Doppler US reveals normal hepatic arteries wave forms 
  
Fig. 5. (A) Celiac angiogram demonstrates sever stenosis at the anastomosis (arrow).  
(B) Hepatic artery stenosis (arrow) confirmed with selective proper hepatic angiogram with 
a small outpouching due to a ligated gastrodoudenal artery (arrowhead). (C) Post angioplasty 
with no significant residual stenosis 
www.intechopen.com
Minimal Invasive (Endovascular and Percutaneous)  
Treatment of Post Liver Transplantation Complications in Pediatrics 
 
249 
 
Fig. 6. Hepatic artery stenosis treated with stent. (A,B,C) angiogram of the aorta-hepatic 
artery conduit with persistent severe stenosis (arrow in A) in the proper HA. As stenosis 
persists after angioplasty (arrowhead in B), it was treated with a 4 x 20 mm balloon 
expandable stent (arrow in C). Stenosis is resolved in post stenting angiogram (C).  
(D) Follow up MRA demonstrates stent artifact in the proper hepatic artery with adequate 
flow proximal and distal to the stent 
3.2.2 Hepatic artery thrombosis 
In the past, hepatic artery thrombosis was the most common and dreads vascular complication 
of orthotopic liver transplantation, with a prevalence of 4%–12% in adult recipients, a 
prevalence of up to 40% in children, and a mortality rate of 50%–58% (Mazzaferro et al, 
1989). Microsurgical techniques have improved these results, and the prevalence of hepatic 
artery thrombosis during the first thirty days after transplantation has been reduced to 
approximately 5% in whole liver transplantation (Settmacher et al, 2000). However, hepatic 
artery thrombosis is more common in split or living donor liver transplantation (Ghobrial et 
al, 2000; Hashikura et al, 2001; Katyal et al, 2000). Associated risk factors include prolonged 
cold ischemia time of the donor liver, previous orthotopic liver transplantation, significant 
differences in caliber between the donor and recipient hepatic arteries, an interposition 
conduit for the anastomosis, small donor or recipient vessels, acute rejection, ABO blood 
type incompatibility, and cytomegalovirus infection (Crossin et al, 2003; Dodd, 1995; 
Vivarelli et al, 2004). As in hepatic artery stenosis, clinical manifestations vary considerably, 
ranging from mild elevation of liver enzyme levels to delayed bile leak, bile duct stricture or 
ischemic changes, or fulminant hepatic necrosis (Ametani et al, 2001; Dodd et al, 1994; Ito et 
al, 2000). Patency of the hepatic artery is vital for long-term survival of the graft because this 
artery is the sole blood supply to the biliary epithelium of the transplanted liver, unlike in a 
native liver (Crossin et al, 2003; Kaneko et al 2004). As a result, complete occlusion of the 
hepatic artery results in infarction or necrosis of the liver parenchyma and may lead to 
fulminant hepatic failure in the early post-transplantation period. Doppler US allows correct 
identification of hepatic artery thrombosis in up to 90% of cases (Crossin et al, 2003; Garcı´a-
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Criado et al, 2003; Glockner & Forauer 1999; Nghiem et al, 1996). At doppler US 
examination, there is usually complete absence of both proper hepatic and intrahepatic 
arterial flow (Chong, 2004; Kok T et al, 1998; Nghiem et al, 1996). The initial doppler 
waveform of the hepatic artery may be normal, with follow-up doppler US images showing 
a progressive decrease in systolic and diastolic flow, followed by absent diastolic flow, 
dampening of the systolic peak, and, finally, total loss of the hepatic waveform (Nolten & 
Sproat, 1996). After thrombosis, arterial collateral vessels can develop, especially in children, 
and intrahepatic flow may be identified. Nevertheless, the intra-hepatic arterial waveform 
will display a tardus parvus pattern with an acceleration time greater than 80 msec and a 
resistive index less than 0.5 (Chong, 2004; Crossin et al, 2003; Dodd, 1995). Therefore, a 
complete absence of flow in the main hepatic artery and a tardus parvus pattern in the 
intrahepatic branches of the hepatic artery are highly suggestive of hepatic artery 
thrombosis and should be confirmed with other imaging techniques (Hall et al, 1990). MR 
angiography is a useful and noninvasive method for evaluating the patency of the hepatic 
artery and may play an important role in identifying patients who require hepatic 
angiography (Glockner et al, 2000; Ito et al, 2000). When thrombosis is present, MR 
angiography accurately demonstrates the location of the thrombus by showing arterial 
opacification up to the thrombus, abrupt cutoff of the hepatic artery at the thrombus, and 
lack of opacification of distal branches (Fig. 7a) (Glockner et al, 2000; Ito et al, 2000).  
 
Fig. 7. Hepatic artery thrombosis (A) MRA demonstrating common hepatic artery (arrow) 
visualized to the level of the anastomosis, and complete occlusion of the hepatic artery 
beyond the anastomosis. (B) Selective celiac angiogram confirms hepatic artery thrombosis 
Angiography is useful when fibrinolytic endovascular therapy is indicated (Fig. 7b). With 
early diagnosis, thrombectomy and revision of the transplant can be used to salvage the 
graft. Thrombolysis has high risk of hemorrhage in early hepatic artery thrombosis, 
especially if associated with liver infarction. If occlusion occurs at a late stage, the graft may 
survive with the support of portal venous flow, but there may be necrosis of the bile duct 
epithelium and consequent biliary strictures or leaks (Chong, 2004; Lorenz et al, 2001). Late 
hepatic artery thrombosis can be treated safely with thrombectomy, fibrinolysis, angioplasty 
and stenting Fig. 8. 
3.2.3 Hepatic artery pseudoaneurysms (HAP) 
Hepatic artery pseudoaneurysm is a rare complication after liver transplantation seen mostly 
at the donor-recipient anastomosis and less often at the ligation site of the gastrodoudenal 
artery and those are likely related to infection, technical failure or biliary leakage. Intrahepatic 
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pseudoaneurysm can also be seen and may be related to percutaneous biliary procedures or 
liver biopsies. Mycotic hepatic artery pseudoaneurysm can fistulize to the portal vein or 
bilary tree and presents with hemobilia, gastrointestinal bleeding or hemoperitoneum. 
Endovascular treatment may be performed by transcatheter or percutaneous coil 
embolization or exclusion of the pseudoaneurysm with covered stent (Figs. 9&10). Surgical 
excision and revascularization using bypass graft can also be performed. 
 
Fig. 8. Management of late hepatic artery thrombosis (A) Pre- and (B) Post-thrombolysis 
hepatic angiograms demonstrating recanalization of the hepatic artery (arrow). Sever 
stenosis (arrowhead) is seen at the hepatic artery bifurcation. (C) The stenosis was 
angioplastied with a 5 x 20 mm balloon (arrow) with no residual stenosis seen in the final 
angiogram (D) 
3.2.4 Hepatic vein stenosis\thrombosis 
Hepatic vein stenosis with resultant outflow insufficiency is a major postoperative 
complication that leads to graft failure in 5% of pediatric liver transplant recipients; most 
often in those with a partial liver graft (Buell et al, 2002) and Piggy back hepatic venous 
anastomosis. Hepatic veins stenosis usually produce hepatic congestion, refractory ascites 
and alteration of liver function test results. Transjugular or transfemoral angioplasty or 
metallic stent placement usually is selected as the first-line treatment for this complication 
(Cheng et al, 2005; Lorenz et al, 2006). In pediatric patients, balloon dilation is the preferred 
treatment choice because the long-term patency of metallic stents is unknown and repeat 
transplantation is always possible. Metallic stent placement should be reserved for the 
treatment of persistent hepatic vein stenosis that is unresponsive to multiple angioplasties. 
The persistence of a pressure gradient of more than 5 mm Hg between the hepatic vein and 
the right atrium after several angioplasties is an indication for metallic stent placement 
(Lorenz et al, 2006). Good technical and clinical success rates are reported after hepatic veins 
angioplasty and stenting with patency rates ranging from 70% at 3 months to 50% at 36 
months (Lorenz et al, 2006). Long term patency may require repeated interventions. In adult 
www.intechopen.com
 Liver Transplantation – Technical Issues and Complications 
 
252 
and pediatric patients in whom transjugular or transfemoral recanalization of the stenotic or 
occluded hepatic vein stenosis has failed, the use of a percutaneous transhepatic approach 
or a combined transhepatic-transjugular approach has been reported (Kubo et al, 2006; 
Miraglia et al, 2007). For the transhepatic approach, preprocedural drainage of ascites and 
postprocedural embolization of the transhepatic tracts are, in our opinion, mandatory to 
reduce the risk of bleeding. Hepatic vein stenosis usually occurs at the anastomosis site; less 
frequently, an intrahepatic stenosis is found that is likely due to injury of the hepatic vein 
during a previous surgical or percutaneous procedure (eg, biopsy or biliary catheter 
placement). Treatment is performed with angioplasty or metallic stent placement (Fig. 11). 
Doppler US should be performed the day after the procedure for a baseline evaluation of the 
hepatic vein velocity and flow spectrum, which are compared with the findings at follow up 
Doppler US evaluations. Imaging follow-up is performed every 3 months in the first post 
procedural year or at any occurrence of ascites or any alteration in liver function test results,  
  
Fig. 9. Management of hepatic artery pseudoaneurysms (HAP). (A,B,C) Extrahepatic 
aneuryusm: (A) MRA and (B) graft hepatic angiogram revealing an outpouching (HAP) at 
the lateral aspect of the graft (arrowhead). (C) After stent graft deployment, angiogram 
reveals no further filling of the Pseudoaneurysm. (D,E,F) Intrahepatic HAP s/p ERCP (D&E) 
catheter angiography shows a bilobed collection of contrast from the right hepatic artery 
(arrow) in this patient with hemobilia. (F) Post-coil embolization (arrowhead), no filling of 
the HAP is seen 
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Fig. 10. Management of hepatic arteriovenous fistula. (A) Right hepatic angiogram reveals 
filling of the portal vein (arrowhead) and the hepatic artery (arrow) at the same time.  
(B) Post coil embolization reveals minimal filling of the fistulous communication (arrow) 
 
Fig. 11. Management of hepatic vein stenosis\thrombosis. (A) Doppler US reveals thrombus 
in the left hepatic vein (arrow) with abnormal monophasic flow. (B) Hepatic venogram 
reveals patent hepatic veins-IVC anastomosis and non-occlusive thrombus (arrow) in the 
hepatic vein confluent. (C) After local thrombolysis, thrombectomy and venoplasty, 
improved flow with residual thrombus (arrow) 
both being suggestive of stenosis recurrence. If clinical or imaging signs of recurrent stenosis 
are present, hepatic vein phlebography with trans-stenotic pressure gradient measurement 
is recommended. 
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3.2.5 Inferior vena cava stenosis\thrombosis 
Inferior Vena Cava (IVC) stenosis is more common in the pediatric population, especially 
among recipients of partial liver transplants, including living donor liver transplants, 
reduced-size liver transplants, and split liver transplants (Carnevale et al, 2004; Egawa et al, 
1997). IVC stenosis may occurs acutely secondary to an anastomotic size discrepancy or 
suprahepatic caval kinking from organ rotation. Delayed caval stenosis may occur 
secondary to fibrosis, a chronic thrombus, or neointimal hyperplasia (Carnevale et al, 2004; 
Katyal et al, 2000). Clinical manifestations include pleural effusions, hepatomegaly, ascites, 
and lower extremity edema. A significant suprahepatic caval stenosis may result in reversed 
flow or absence of phasicity in the hepatic veins (Crossin et al, 2003). Nevertheless, 
monophasic waveforms are not specific for hepatic vein stenosis (Chong, 2004). A 
monophasic flat waveform with a relatively low average peak velocity in the hepatic vein 
(mean, 11 cm/sec) is a common finding. Sometimes, graft growth and twisting are causes of 
IVC pseudostenosis (Ametani et al, 2001), which may increase or disappear depending on 
the patient’s posture. Hemodynamically significant IVC stenosis can be differentiated from  
pseudostenosis on the basis of the presence of features of Budd-Chiari syndrome and 
Doppler velocity measurements. IVC stenosis and hepatic vein stenosis may manifest as 
Budd-Chiari syndrome, with hepatomegaly, ascites, reversed flow or absence of phasicity in 
the hepatic veins, and reversed flow in the portal vein (Buell et al, 2002; Crossin et al, 2003; 
Katyal et al, 2000). Contrast-enhanced CT is useful in demonstrating congestive changes in 
the liver parenchyma as a manifestation of blocked outflow but is of little help in depicting 
the stenosis itself (Ametani et al, 2001; White et al, 2004). Coronal MR imaging is useful in 
determining the extent of IVC stenosis and associated anomalies (Ito et al, 2000). Frequently, 
cavogram is required to confirm the stenosis. Pressure gradient measurements can help 
distinguish physiologically significant lesions from pseudostenoses (Carnevale et al, 2004). 
Treatment includes IVC recanalization, balloon angioplasty and stent placement (Fig. 12). 
Color Doppler US performed after the interventional procedure is also useful in confirming 
the restoration of normal hepatic venous flow by demonstrating a multiphasic waveform 
and an objective increase in flow velocity (Huang et al, 2004; Totsuka et al, 2004). Ascites 
usually disappears rapidly after the procedure. IVC thrombosis is a rare occurrence. It tends 
to occur at the superior and inferior caval anastomoses. Risk factors include technical 
problems during transplantation, use of intravascular catheters, and compression of vessels 
by a fluid collection. Color Doppler US may reveal obvious vessel narrowing or an 
echogenic intraluminal thrombus with absence of flow. At MR angiography, IVC 
thrombosis is seen as an intraluminal defect. Coronal imaging is useful for determining the 
extent of IVC thrombosis (Chong, 2004; Glockner et al, 2000). 
3.2.6 Portal vein stenosis 
Portal vein stenosis has been reported to occur as a postoperative complication in 4%–8% of 
pediatric liver transplant recipients (Ueda et al, 2005). It occurs more frequently in reduced-
size liver transplantation than in whole liver transplantation owing to the limited length of 
the portal vein that can be obtained from the donor (Unsinn et al, 2003). A difference in 
caliber between donor and recipient portal veins is normal and can be helpful in locating the 
portal venous anastomosis. An echogenic shelf like ring can often be seen at the anastomotic 
site. These findings should not be misinterpreted as a stenosis. At gray-scale US, portal vein  
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Fig. 12. Managment of IVC occlusion. (A&B) CT.scan of the upper abdomen demonstrating 
absence of the suprahepatic IVC in (A) and congested azygus vein (arrow) in B. (C) Initial 
cavogram confirms the occlusion of the IVC with opacification of the azygus system. (D&E) 
Successful recanalization and stenting of the IVC. The arrow in E points to the piggyback 
stump. (F) Follow up cavogram after six months confirms the patency of the stented IVC 
stenosis is diagnosed when a reduction of the vessel lumen of 50% or more is observed (Fig. 
13) at the site of narrowing relative to the prestenotic area, or when the caliber of the vessel 
is 2.5 mm or less at the site of narrowing (Boraschi & Donati, 2004; Crossin et al, 2003; 
Glockner & Forauer, 1999). Color Doppler US shows focal color aliasing at the vascular 
anastomosis. At pulsed doppler US, the waveform shows a systolic velocity greater than 20 
m/sec or a velocity in the stenotic segment that is three to four times greater than that in the 
prestenotic segment. A poststenotic jet with a velocity between 1 and 3 m/sec is a 
characteristic finding (Crossin et al, 2003; Nghiem et al, 1996; Stell et al, 2004). MR 
angiography can provide excellent visualization of portal vein stenosis (Fig. 13). Portography 
helps confirm the presence of the stenosis, and a pressure gradient may be obtained to 
determine the hemodynamic significance of the stenosis (Nghiem, 1996).Clinical symptoms 
of hemodynamically significant portal vein stenosis are related to portal hypertension and 
include bleeding from varices, splenomegaly, and ascites. Percutaneous transhepatic 
angioplasty is considered the standard treatment for portal vein stenosis. The placement of 
metallic stents also has been reported for treatment of recurrent or nonresponsive elastic 
stenosis (Funaki et al, 2000; Zajko et al, 1994). In the largest patient series for which data are 
available, a very good patency rate of 100% was found at 46 months after treatment with 
angioplasty and metallic stent placement (Funaki et al, 2000). A transhepatic puncture of the 
portal vein is performed with a 21-gauge needle while using US for guidance. An introducer 
system is advanced over an 0.018-inch nitinol wire to the portal branch and then exchanged 
for a 6-F vascular sheath over a 0.035-inch wire. The trans-stenotic pressure gradient is 
measured by using a 5-F hydrophilic catheter. Before balloon dilation, a bolus of heparin 
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(100 IU/kg) is administered intravenously to reduce the risk of thrombosis during balloon 
induced occlusion. Technical success is represented by resolution of the stenosis on a follow-
up portogram and by a significant reduction in the trans-stenotic pressure gradient (Fig. 14). 
The persistence of a pressure gradient of more than 5 mm Hg has been considered an 
indication for metallic stent placement (Funaki et al, 2000). Coil or gelfoam embolization of 
transhepatic needle tracts can be done to reduce the risk of bleeding. Doppler US should be 
performed on the day after the procedure for baseline evaluation of the portal vein velocity 
and flow spectrum. If findings at doppler US or clinical signs are suggestive of stenosis 
recurrence, MRI can be performed to confirm the findings before percutaneous intervention 
is repeated. 
 
Fig. 13. Portal vein stenosis. (A&B) MRA reveals moderate stenosis (arrow) of the main 
portal vein. (C&D) US and color US shows portal vein stenosis and turbulent flow 
  
Fig. 14. Angioplasty of portal vein (PV) stenosis. (A&B) Percutaneous portogram reveals 
saccular dilatation of the portal vein (arrowhead) and moderate stenosis at the PV anastomosis 
(arrow) with an 8 mm pressure gradient noted. (C&D) Post venoplasty with 6 x 40 mm 
balloon, mild residual stenosis is noted with gradient drop to 3 mm Hg indicating successful 
treatment. (E) follow up US demonstrates improved velocities and decrease in the spatial 
gradient across the stenosis 
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3.2.7 Portal vein thrombosis 
Portal vein thrombosis occurs more frequently in reduced size liver transplantation, mostly 
involving the main extrahepatic portal segment. Risk factors include surgical difficulties, 
decreased portal venous inflow; the presence of portosystemic shunts before transplantation; 
prior splenectomy; excessive vessel redundancy; and use of the venous conduits, most 
commonly cryopreserved iliac veins (Buell et al, 2002; Hashikura et al, 2003; Nghiem, 1998). 
Clinical manifestations include new-onset massive ascites, variceal bleeding, elevated values 
on hepatic function tests, splenomegaly, hepatic failure, and lower extremity edema (Buell et 
al, 2002; Millis et al, 1996). An acute thrombus is frequently anechoic and may be 
imperceptible on gray-scale US images and the portal vein appears normal. In these cases, 
color flow and spectral doppler analysis will show no detectable flow within the portal vein 
(Langnas et al, 1991; Nghiem, 1998). Vessel narrowing or an echogenic luminal thrombus 
with no Doppler flow may also be seen (Nghiem et al, 1996). Partial portal vein thrombosis 
may appear as a nonocclusive filling defect at US. Resultant luminal narrowing can be 
mistaken for portal vein stenosis at gray-scale, spectral, and color doppler US (Funaki et al, 
2000; Langnas et al, 1991). Occasionally, reversed flow in the intrahepatic branches may be 
observed in patients with portal vein thrombosis with complete absence of flow in the main 
portal vein. This finding is due to arterioportal shunts that develop soon after the 
thrombosis. Care should be taken to avoid making a false-negative diagnosis (Nghiem, 1996, 
1998; Stell et al, 2004). MR venography can provide an excellent visualization of portal vein 
thrombosis and can facilitate the differentiation of thrombosis from slow flow (Stafford-
Johnson et al, 1998; Unsinn et al, 2003). At contrast material–enhanced CT, portal vein 
thrombosis is seen as a low-attenuation filling defect (Ametani et al, 2001; Garcı´a-Criado et 
al, 2003; Unsinn et al, 2003). Portal vein stenosis with thrombus formation in the immediate 
postoperative period is quickly diagnosed with Doppler US and is managed surgically. 
Treatment of portal vein thrombosis may include mechanical thrombectomy, segmental 
portal vein resection, percutaneous thrombolysis and stent placement, or balloon 
angioplasty (Fig. 15) (Holbert et al, 1995; Rossi et al, 2004). However, when the thrombus 
extends to the periphery of the intrahepatic portal venous branches, it can no longer be 
treated with balloon dilation or thrombolysis, and the patient must undergo repeat 
transplantation (Ametani et al, 2001). Thus, early diagnosis of portal vein thrombosis before 
formation of a complete thrombus is important. Occasionally, portal vein thrombosis is  
  
Fig. 15. Portal vein thrombosis. (A) Percutaneous portogram reveals occlusion of the main 
portal vein. (B) The portal vein was recanalized and thrombectomy was performed. (C) Post 
recanalization portogram reveals patent mesenteric veins (arrow) with filling of collateral 
varices 
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detected in patients with normal allograft function and no portal hypertension. In these 
patients, sufficient hepatopetal collateralization has developed to maintain adequate venous 
flow (Holbert et al, 1995; Unsinn et al, 2003). A cavernomatous transformation is the usual 
finding at Doppler US in these cases. 
3.3 Biliary complications imaging and treatment 
Biliary complications are the most common complications following pediatric liver 
transplantation estimated to involve 20%–40% of pediatric liver transplant recipients, more 
frequently seen in children who have undergone reduced-size transplantation. Most biliary 
complications develop during the first 3 months after pediatric liver transplantation, but 
strictures and stones may develop months or years later. Complications include anastomotic 
leakage and stenosis with bile duct dilatation; intrahepatic bile duct stones, sludge, or 
debris; and biloma. These complications are related to the surgical method of biliary 
reconstruction and to prolonged cold ischemia time, immunologic reactions, hepatic artery 
thrombosis, ABO blood group system incompatibility between donor and recipient, and 
cytomegalovirus infection (Ametani et al, 2001). Non-anastomotic strictures are probably 
caused by hepatic arterial insufficiency from either stenosis or thrombosis. These ischemic 
arterial events may result in bile duct strictures or leaks, increasing the risk of cholangitis, 
sepsis, and abscess (Boraschi & Donati, 2004; Glockner & Forauer, 1999). The blood supply 
to the recipient CBD is rich because of collateral flow, whereas the vascularity of the donor 
duct and the proximal intrahepatic ducts is derived solely from the reconstructed hepatic 
artery. Biliary disease should be suspected in a post-transplantation patient who presents 
with elevated values on hepatic function tests, jaundice, fever, or abdominal pain (Lorenz et 
al, 2001; Vitellas & Guttikonda, 2002). The clinical manifestations of biliary complications 
often are indistinguishable from those of vascular complications, graft rejection, graft 
dysfunction, and infections. Although US is commonly performed to screen for biliary 
complications, the false-negative rate is high; therefore, negative findings at US do not 
suffice to exclude biliary complications. MRCP can be used as a non-invasive imaging tool 
to confirm US findings. Percutaneous trans-hepatic cholangiography can depict the type, 
location, and severity of biliary complications, allowing treatment in many cases. 
3.3.1 Anastomotic biliary strictures 
Anastomotic biliary strictures are a common problem after pediatric liver transplantation, 
with a reported incidence of 10%–35% (Lallier et al, 1993; Heffron et al, 1992). Such strictures 
are usually related to scar tissue and retraction at the suture site. Untreated biliary strictures 
are associated with high morbidity and mortality. Because hepatico-jejunostomy with Roux-
en-Y reconstruction is the most common type of biliary anastomosis in pediatric liver 
transplant recipients, endoscopy is rarely feasible and percutaneous intervention is usually 
the only treatment approach possible. Percutaneous treatment of biliary strictures in 
pediatric liver transplant recipients is considered safe and effective, and in most cases 
obviates surgical revision of the affected anastomoses (Lorenz et al, 2005; Schwarzenberg et 
al, 2002). Possible complications of percutaneous transhepatic cholangiography include 
hemobilia, intra- or extrahepatic hematoma, and fever with bacteremia; a cumulative 
incidence of 10.8% is reported for these complications in the pediatric population (Lorenz et 
al, 2005). Among 35 pediatric liver transplant recipients who underwent percutaneous 
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treatment of biliary strictures, the reported success rate was 34% after a single course of 
therapy and 60% after repeat percutaneous therapy, with a median follow-up period of 4.5 
years (Sunku et al, 2006). Suspicion about the presence of a biliary stricture may be aroused 
by one or more of the following findings, clinical manifestations such as fever or cholangitis; 
biochemical indicators such as increased levels of alkaline phosphatase, direct bilirubin, and 
transaminases; biliary duct dilatation observed at US, CT, or MR imaging; and liver biopsy 
with histologic findings indicative of cholestasis due to biliary obstruction. Biliary strictures 
may be present also in the absence of ductal dilatation (Berrocal et al, 2006). Some investigators 
have reported better sensitivities (80%–100%) when using MR cholangiography for the 
detection of biliary obstruction (Kitazono et al, 2007; Norton et al, 2001). However, in 
pediatric patients, deep sedation or general anesthesia is necessary during MR 
cholangiography and adds considerably to the cost of management; for this reason, MR 
cholangiography is not generally used as a screening modality in children. It does afford a 
global evaluation of the ductal anatomy, a capability that might be especially helpful when 
planning the placement of a biliary drainage catheter in a patient with two separate 
hepaticojejunostomies and a nondilated bile duct, because it allows avoidance of puncture 
of a hepatic segment with a normal bile duct. As an alternative, hepatobiliary scintigraphy 
with technetium 99m Mebrofenin iminodiacetate could be performed, with a segmental 
delay in clearance of the radiotracer being suggestive of a biliary stricture. Percutaneous 
transhepatic cholangiography is performed to confirm clinical, histologic, or imaging 
evidence of biliary strictures. Percutaneous transhepatic cholangiography is performed with 
monitored anesthesia care, spontaneous respiration, and additional local anesthesia. 
Intravenous antibiotic prophylaxis is administered before the procedure. If coagulation 
defects (platelet count < 50 × 1000/μL, prothrombin activity < 50%) are present, the patient 
receives an infusion of platelets, fresh frozen plasma, or both. Percutaneous transhepatic 
cholangiography is usually performed with a subxiphoid approach by using a 20-gauge 
needle positioned in a peripheral bile duct with US and fluoroscopic guidance. If the 
cholangiogram shows an anastomotic stricture, the biliary tree is catheterized by using an 
introducer system over a nitinol wire; the stricture is crossed, when possible, with 0.035- or 
0.038-inch hydrophilic wire, and a transanastomotic biliary catheter (diameter range,  
5–6.6 F) is placed with side holes above and below the stricture (Fig. 16).  
The catheter is left in place to allow external gravity drainage for at least 1 day. If the patient 
has no fever or cholangitis the day after the procedure, the catheter is clamped to allow 
internal drainage. Diagnostic cholangiography and the first session of balloon dilation of the 
anastomosis are performed on different days to reduce the risk of sepsis. The first session of 
balloon dilation is usually performed 1 week after cholangiography, with a 5-F or 6-F sheath 
and with a balloon size ranging from 5 mm to 7 mm at a pressure of 6–11 atm. The balloon 
size selected is usually 1 mm larger than the diameter of the intrahepatic bile duct above the 
stricture. In every session, trans-anastomotic balloon dilation should be performed three 
times, 10 minutes each. A transanastomotic biliary catheter is placed after every session of 
dilation, with the catheter size ranging from 6 to 12 F, according to the diameter of the 
anastomosis. The antibiotic infusion is repeated 6 hours after the procedure. A minimum of 
three separate sessions of biliary anastomotic dilations are performed, followed by a 
cholangiographic evaluation, and if necessary, further sessions of dilation every 4–6 weeks. 
At each session of dilation, the size of the balloon catheter is increased by 1 mm, until a 
maximum diameter of 10 mm is reached. The drainage catheter is finally removed when   
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Fig. 16. Anastomotic biliary stricture. (A) Percutaneous cholangiogram demonstrating 
dilated biliary ducts with total occlusion of the hepatico-jejunostomy (arrow). (B) Successful 
recanalization and a balloon cholangioplasty of the biliary anastomosis. (C) Final 
cholangiogram demonstrated patent anastomosis with contrast drained into the jejunum. 
(D) Internal\external biliary drain placed across the anastomosis 
cholangiography performed through a sheath depicts resolution of the stricture and a good 
transanastomotic bile flow, which is defined as a complete passage of contrast material from 
the bile duct to the bowel loop within three minutes after injection. Biliary manometry or 
clinical trial using a capped “end-hole” catheter proximal to the treated duct or anastomosis 
can also be performed to determine the treatment success and the resolution of the 
anastomotic biliary stricture (Scott et al, 1998). In up to 41% of left lateral split-liver 
transplant recipients, the ducts for segments II and III are separately anastomosed to the 
jejunum (Broelsch et al, 1991). In these patients, biliary strictures may develop in one or both 
anastomoses (Fig. 17 a&b). For this reason, it is mandatory to know the number of 
hepaticojejunostomies present in a patient before performing percutaneous transhepatic 
cholangiography. In partial liver transplant recipients with an occlusive anastomotic biliary 
stricture that is not traversable with standard interventional radiology techniques, sharp 
percutaneous recanalization of the hepaticojejunostomy may be performed using a long 
needle, thus obviating surgery (Miraglia et al, 2007) (Fig. 17 C&D). 
3.3.2 Intrahepatic biliary strictures and bilomas 
Intrahepatic biliary strictures are usually related to chronic transplant rejection or arterial 
insufficiency caused by hepatic artery stenosis or thrombosis. A single focal stricture or 
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multiple or combined intrahepatic and anastomotic strictures may be present (Fig. 18). 
Percutaneous treatment of intrahepatic biliary strictures is usually performed with the same 
techniques used for anastomotic biliary strictures; however, a recurrence rate of 90% was 
reported in a long-term follow-up study of intrahepatic strictures (Sunku et al, 2006).  
Intrahepatic bilomas develop in the presence of arterial insufficiency due to hepatic artery 
stenosis or thrombosis or because of ABO incompatibility. Bilomas frequently are infected 
by gram-negative organisms that enter via the biliary anastomosis from the gastrointestinal 
tract. Percutaneous drainage of intrahepatic bilomas usually is performed with US guidance 
and is mandatory to reduce the risk of sepsis and graft loss (Hoffer et al, 1988). 
3.3.3 Bile leakage 
Postoperative bile leakage is a complication that usually occurs within few weeks after 
pediatric liver transplantation. Bile may leak from the bile duct anastomosis or from the 
resection margin in a split-liver transplant. Nonanastomotic leaks are usually associated 
with hepatic artery thrombosis.  
  
Fig. 17. Sharp recanalization of occlusive hepatico-jejunostomy. (A&B) MRI coronal images 
and MRCP demonstrating two separate heptico- jejunostomy with multiple filling defects in 
the superior bile duct. (C) Cholangiogram demonstrated external drain in the lower 
segmental bile duct with total occlusion of the inferior anastomosis, a plastic stent is noted 
across the superior anastomosis. (D) S/p sharp recanalization of the inferior anastomosis 
with the contrast drained through the anastomosis into the jejunum 
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Fig. 18. Ischemic biliary duct injuries. (A) Intra-hepatic biliary ducts stenosis seen by ERCP 
cholangiogram. (B) Combined intra-hepatic and anastomotic biliary stricture 
  
Fig. 19. (A) CT showing multiple bilomas (arrows). (B) Percutanous  cholangiogram reveals 
irregular and dilated bile ducts (arrow) consistent  with ischemic injury due to hepatic 
artery thrombosis. (C) Percutaneous  cholangiogram in different duct reveals a small biloma 
(arrowhead). (D)  Follow up CT of the abdomen reveals resolving bilomas with draining 
catheter in site (arrow). Retroperitoneal lymphadenopathy (curved arrow) consistent with 
post transplant lymphoproliferative disorder (PTLD) 
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Fig. 20. (A&B) ERCP demonstrating bile leakage from CHD (arrow in A) and stricture at the 
distal CBD (arrowhead). Plastic stent is placed through the scop (arrow in B). (C) Percntaneous 
cholangiogram after the removal of the internal stent revealing a kink and narrowing at the 
CBD anastomosis (arrow). (D) 6.5 Fr internal\external drainage catheter was placed 
Another possible site of leakage is the T-tube insertion in patients with a choledocho-
choledochal anastomosis. Small leaks usually resolve spontaneously; whereas large ones are 
associated with significant morbidity and occasional mortatlity, thus require treatment. 
Clinical manifestation of bile leak vary, and can be presented as fever, abdominal pain, fluid 
and electrolyte depletion, fat malabsorption, and the possibility of sepsis or bleeding due to 
hilar vascular erosion. The bile extravasates into the peritoneal cavity or forms a perihepatic 
fluid collection. These fluid collections are usually well depicted at US. Percutaneous 
drainage catheters are placed with US guidance to drain these large bile collections. Bile leak 
can be confirmed by hepatobiliary scintigraphy with Technitum 99m Mebrofenin 
iminodiacetate. Recently, MR cholangiography performed with specific contrast agents has 
proved useful in the diagnosis of small bile leaks (Akin et al, 2004; Vitellas & Guttikonda, 
2002). Adult patients who have undergone endoscopic or percutaneous transhepatic 
treatment for large bile leaks have experienced good outcomes obviating surgical repair in 
most cases (Akin et al, 2004; Kok et al, 1996). In pediatric liver transplant recipients, 
percutaneous transhepatic cholangiography and biliary catheter placement may be 
attempted for the treatment of large bile leaks from anastomoses only if the bile duct and the 
jejunal loop have not completely separated. A modified multipurpose drainage catheters 
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can be placed in the intrahepatic biliary ducts crossing the leaking anastomosis into the 
distal bowel loop by adding holes proximally to reduce the contact between the bile and the 
anastomotic lesion and thereby facilitate the repair process Fig. (20). Surgical revision often 
is necessary or strongly recommended if cholangiography shows complete separation of the 
bile duct from the jejunal loop. 
  
Fig. 21. Percutaneous retrieval of biliary stones. (A) a basket inserted co- axially with the 
cholangioscope through a large percutaneous access sheath  to the left hepatic duct. (B) On 
table mage shows the retrieved stones. (C and D) pre and post stone retrieval 
cholangiogram demonstrated successful treatment with no residual stone and resolution of 
the biliary duct dilatation 
3.3.4 Bile duct stones 
Although stones and sludge occur only infrequently after transplantation, they are 
associated with high morbidity. Several factors can lead to the formation of biliary stones 
and sludge. Cyclosporine can alter the bile composition, inducing crystal formation, which 
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results in biliary sludge and stone formation (Fulcher & Turner, 1999). Other causes include 
retained stones within the graft or stones formed secondary to bile stasis from biliary 
strictures. Biliary stones are well depicted with US and MR imaging (Kok et al, 1996; Laghi 
et al, 1999; Linhares et al, 2004). Interventional procedures may be useful for obviating 
surgery in these patients (Lorenz et al, 2005). Biliary stone removal can be performed 
through the percutaneous access to the involved bile duct and the stone can be retrieved 
using a basket or can be fragmented into small pieces using small forceps to drain with the 
bile into the intestine Fig. (21).  
4. Conclusion 
Liver transplantation is the ultimate treatment for children with end-stage liver disease. The 
application of reduced-size transplantation and the development of living related donor 
partial liver transplantation have expanded the donor pool, which, however, has in turn 
increased the risk for vascular and biliary complications. Imaging studies are extremely 
important for early diagnosis of post-transplantation complications because the clinical 
manifestations of these complications are frequently nonspecific and vary widely. Doppler 
US plays the leading role in the postoperative evaluation of pediatric patients. It is the 
imaging tool of choice for initial screening for biliary, arterial, and venous complications and 
is helpful in determining the next logical imaging test to confirm these complications. 
Current MR imaging techniques, including MR angiography and MR cholangiography, may 
provide a comprehensive evaluation of the transplanted liver; reveal abnormalities of 
vascular structures, bile ducts, and liver parenchyma; and depict extrahepatic tissues. If 
available, MR imaging should be used when US is inconclusive. CT is a valuable 
complement to US in the evaluation of complications involving the hepatic parenchyma as 
well as extrahepatic sites, especially the thorax. A number of complications can be corrected 
by using interventional radiologic techniques. Advances in minimally invasive, image-
guided percutaneous and endovascular techniques of various vascular and nonvascular 
complications of liver transplantation, have led to improved Graft and patient survival and 
have obviated surgical revision or repeat transplantation in most cases. 
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